US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 0.511
  • 0.000-0.02%
Close Mar 7 16:00 ET
  • 0.530
  • +0.019+3.72%
Post 19:14 ET
30.25MMarket Cap-0.65P/E (TTM)

Elevation Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.82%44.7M
33.93%10.64M
21.14%13.23M
11.48%10.96M
-15.20%9.87M
-57.34%40.34M
-57.13%7.95M
-71.66%10.92M
-51.11%9.83M
-32.99%11.64M
Selling and administrative expenses
8.06%16.11M
22.73%4M
9.81%3.84M
15.95%4.41M
-11.23%3.86M
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
-General and administrative expense
8.06%16.11M
22.73%4M
9.81%3.84M
15.95%4.41M
-11.23%3.86M
-5.86%14.9M
-19.33%3.26M
-16.54%3.5M
-0.21%3.81M
14.58%4.35M
Research and development costs
12.44%28.6M
41.70%6.65M
26.49%9.39M
8.66%6.55M
-17.57%6.01M
-67.69%25.43M
-67.65%4.69M
-78.39%7.42M
-63.01%6.03M
-46.28%7.29M
Operating profit
-10.82%-44.7M
-33.93%-10.64M
-21.14%-13.23M
-11.48%-10.96M
15.20%-9.87M
57.34%-40.34M
57.13%-7.95M
71.66%-10.92M
51.11%-9.83M
32.99%-11.64M
Net non-operating interest income expense
625.33%1.2M
283.93%215K
22.03%360K
289.30%513K
137.22%115K
54.20%-229K
56K
295K
-271K
-309K
Non-operating interest income
31.02%5.2M
----
----
----
----
297.10%3.97M
----
----
----
----
Non-operating interest expense
-4.76%4M
----
----
----
----
180.00%4.2M
----
----
----
----
Total other finance cost
----
----
-22.03%-360K
-289.30%-513K
-137.22%-115K
----
----
---295K
--271K
--309K
Other net income (expense)
81.55%-942K
0
81.55%-942K
-85,016.67%-5.11M
0
-5,591.40%-5.11M
Special income (charges)
81.55%-942K
--0
--0
--0
81.55%-942K
---5.11M
--0
--0
--0
---5.11M
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
--0
--5.11M
--0
--0
--0
--5.11M
-Less:Other special charges
--942K
--0
----
----
--942K
----
----
----
----
----
Income before tax
2.70%-44.44M
-32.15%-10.43M
-21.12%-12.87M
-3.41%-10.45M
37.28%-10.7M
51.95%-45.67M
58.51%-7.89M
72.64%-10.63M
49.29%-10.11M
1.28%-17.05M
Income tax
43.33%43K
0.00%9K
9.09%12K
120.00%11K
120.00%11K
20.00%30K
-64.00%9K
11K
5K
5K
Net income
2.67%-44.49M
-32.12%-10.44M
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
Net income continuous Operations
2.67%-44.49M
-32.12%-10.44M
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
Minority interest income
Net income attributable to the parent company
2.67%-44.49M
-32.12%-10.44M
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.67%-44.49M
-32.12%-10.44M
-21.11%-12.88M
-3.47%-10.46M
37.24%-10.71M
51.93%-45.7M
58.52%-7.9M
72.61%-10.64M
49.26%-10.11M
1.25%-17.06M
Basic earnings per share
37.60%-0.78
-63.64%-0.18
4.35%-0.22
50.00%-0.18
68.06%-0.23
69.44%-1.25
86.59%-0.11
86.23%-0.23
58.14%-0.36
2.70%-0.72
Diluted earnings per share
37.60%-0.78
-63.64%-0.18
4.35%-0.22
50.00%-0.18
68.06%-0.23
69.44%-1.25
86.59%-0.11
86.23%-0.23
58.14%-0.36
2.70%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.82%44.7M33.93%10.64M21.14%13.23M11.48%10.96M-15.20%9.87M-57.34%40.34M-57.13%7.95M-71.66%10.92M-51.11%9.83M-32.99%11.64M
Selling and administrative expenses 8.06%16.11M22.73%4M9.81%3.84M15.95%4.41M-11.23%3.86M-5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M
-General and administrative expense 8.06%16.11M22.73%4M9.81%3.84M15.95%4.41M-11.23%3.86M-5.86%14.9M-19.33%3.26M-16.54%3.5M-0.21%3.81M14.58%4.35M
Research and development costs 12.44%28.6M41.70%6.65M26.49%9.39M8.66%6.55M-17.57%6.01M-67.69%25.43M-67.65%4.69M-78.39%7.42M-63.01%6.03M-46.28%7.29M
Operating profit -10.82%-44.7M-33.93%-10.64M-21.14%-13.23M-11.48%-10.96M15.20%-9.87M57.34%-40.34M57.13%-7.95M71.66%-10.92M51.11%-9.83M32.99%-11.64M
Net non-operating interest income expense 625.33%1.2M283.93%215K22.03%360K289.30%513K137.22%115K54.20%-229K56K295K-271K-309K
Non-operating interest income 31.02%5.2M----------------297.10%3.97M----------------
Non-operating interest expense -4.76%4M----------------180.00%4.2M----------------
Total other finance cost ---------22.03%-360K-289.30%-513K-137.22%-115K-----------295K--271K--309K
Other net income (expense) 81.55%-942K081.55%-942K-85,016.67%-5.11M0-5,591.40%-5.11M
Special income (charges) 81.55%-942K--0--0--081.55%-942K---5.11M--0--0--0---5.11M
-Less：Restructuring and merger&acquisition --0--0--0--0--0--5.11M--0--0--0--5.11M
-Less:Other special charges --942K--0----------942K--------------------
Income before tax 2.70%-44.44M-32.15%-10.43M-21.12%-12.87M-3.41%-10.45M37.28%-10.7M51.95%-45.67M58.51%-7.89M72.64%-10.63M49.29%-10.11M1.28%-17.05M
Income tax 43.33%43K0.00%9K9.09%12K120.00%11K120.00%11K20.00%30K-64.00%9K11K5K5K
Net income 2.67%-44.49M-32.12%-10.44M-21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M
Net income continuous Operations 2.67%-44.49M-32.12%-10.44M-21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M
Minority interest income
Net income attributable to the parent company 2.67%-44.49M-32.12%-10.44M-21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.67%-44.49M-32.12%-10.44M-21.11%-12.88M-3.47%-10.46M37.24%-10.71M51.93%-45.7M58.52%-7.9M72.61%-10.64M49.26%-10.11M1.25%-17.06M
Basic earnings per share 37.60%-0.78-63.64%-0.184.35%-0.2250.00%-0.1868.06%-0.2369.44%-1.2586.59%-0.1186.23%-0.2358.14%-0.362.70%-0.72
Diluted earnings per share 37.60%-0.78-63.64%-0.184.35%-0.2250.00%-0.1868.06%-0.2369.44%-1.2586.59%-0.1186.23%-0.2358.14%-0.362.70%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
NEW WELLLINK
871634
+30.00%
VIBO
871245
+29.99%
MTD
835579
+29.98%
4
REFORMER
833030
+29.98%
5
Hunan Sundy Science And Technology
300515
+20.02%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!